Penile Cancer Mortality in Brazil: Are We Making Progress?
JCO Global Oncology · 2024-02 · (10)
DOI: 10.1200/go.23.00303 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2024-02. Verfasst von Thiago Camelo Mourão und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fundação Antônio Prudente, A.C. Camargo Cancer Center, São Paulo, Brazil. Hauptthemen laut MEDLINE: Penile Neoplasms, Adenomatous Polyposis Coli. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE This study aims to analyze the trends in mortality rates from penile cancer (PeC) and the treatment modalities adopted in Brazil over recent years. MATERIALS AND METHODS Death records for PeC cases (International Classification of Diseases, version 10 C60) and treatment modalities were extracted from the DATASUS database. A joinpoint regression analysis was conducted to examine the data. RESULTS A total of 7,848 deaths due to PeC were recorded in Brazil between 1996 and 2020. Increasing mortality trends were observed, with an average annual percentage change (AAPC) of 0.91 (0.6-1.2; P < .001). The North and Northeast regions had the highest age-standardized mortality rates (ASMRs) and AAPCs. From 2008 to 2020, the ASMR in the Northeast region remained stable, whereas the North region surpassed it. The Southeast region exhibited a significant downward trend, with an AAPC of –0.91 (–1.3 to -0.5; P < .001). Penile biopsies declined and were more frequent in the southeastern region. A total of 8,498 penile amputations were performed, with 39.4% and 29.1% conducted in the Southeast and Northeast regions, respectively. CONCLUSION Brazil has experienced increasing mortality trends in PeC over the past 2 decades. Low schooling, married, and young men from the North or Northeast regions represent the majority of deaths. Urgent efforts are needed to enhance the diagnosis and treatment of PeC to prevent and reduce mortality rates in the country.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Fundação Antônio Prudente, A.C. Camargo Cancer Center, São Paulo, Brazil.
- Department of Urology, Hospital Santa Catarina, São Paulo, Brazil.
- Group of Epidemiology and Statistics on Cancer, International Research Center, A.C. Camargo Cancer Center, São Paulo, Brazil.
- Department of Urology, Hospital São Camilo Pompeia, São Paulo, Brazil.
- National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, São Paulo, Brazil.
- Department of Surgery, Division of Urology, Graduate School, São Paulo Federal University, São Paulo, Brazil.
ORCID-Profile: Thiago Camelo Mourão, Artur Agostinho Beraldi, Gisele Aparecida Fernandes, Plínio Ramos Pinto Neto, Rafael Valente Batista, Stênio de Cássio Zequi
Zitieren
APA
Mourão, T. C., Beraldi, A. A., Fernandes, G. A., Pinto Neto, P. R., Batista, R. V., Nobre, J. Q. C., Curado, M. P., & Zequi, S. C. (2024). Penile Cancer Mortality in Brazil: Are We Making Progress?. JCO Global Oncology. https://doi.org/10.1200/go.23.00303
Vancouver
Mourão TC, Beraldi AA, Fernandes GA, Pinto Neto PR, Batista RV, Nobre JQC, et al. Penile Cancer Mortality in Brazil: Are We Making Progress?. JCO Global Oncology. 2024. doi:10.1200/go.23.00303
BibTeX
@article{Mouro2024,
author = {Mourão, Thiago Camelo and Beraldi, Artur Agostinho and Fernandes, Gisele Aparecida and Pinto Neto, Plínio Ramos and Batista, Rafael Valente and Nobre, Jayme Quirino Caon and Curado, Maria Paula and Zequi, Stênio de Cássio},
title = {Penile Cancer Mortality in Brazil: Are We Making Progress?},
journal = {JCO Global Oncology},
year = {2024},
number = {10},
doi = {10.1200/go.23.00303}
}
EUVIMED